Zivo Bioscience Inc (ZIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,385 | -11,784 | -9,515 | -1,279 | -7,777 |
| Depreciation Amortization | -8 | N/A | 50 | 25 | -171 |
| Accounts receivable | -2 | -24 | 4 | N/A | -4 |
| Accounts payable and accrued liabilities | -424 | -242 | 7 | -249 | 675 |
| Other Working Capital | -397 | -429 | -520 | -557 | 1,281 |
| Other Operating Activity | 9,902 | 9,070 | 7,651 | 361 | 196 |
| Operating Cash Flow | $-4,314 | $-3,408 | $-2,323 | $-1,699 | $-5,800 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 518 | 518 | N/A | 518 | 1,756 |
| Debt Issued | N/A | N/A | 518 | N/A | N/A |
| Debt Repayment | -21 | N/A | -230 | N/A | N/A |
| Common Stock Issued | 5,602 | 3,178 | 1,763 | 1,103 | 4,275 |
| Other Financing Activity | -518 | -403 | 0 | -58 | -1,756 |
| Financing Cash Flow | $5,582 | $3,293 | $2,051 | $1,563 | $4,275 |
| Beginning Cash Position | 274 | 274 | 274 | 274 | 1,799 |
| End Cash Position | 1,542 | 159 | 3 | 139 | 274 |
| Net Cash Flow | $1,268 | $-115 | $-272 | $-136 | $-1,525 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,314 | -3,408 | -2,323 | -1,699 | -5,800 |
| Free Cash Flow | -4,314 | -3,408 | -2,323 | -1,699 | -5,800 |